Also, our laboratory has reported that loss or inhibition of CaMKK2 activity confers protection against diet-induced obesity by improving pancreatic insulin secretion and increasing sensitivity of insulin-responsive tissues (i.e. liver and skeletal muscle)15. The gene discussed is INS; the disease is obesity disorder.